Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Redox and pH gradients drive amino acid synthesis in iron oxyhydroxide mineral systems.

Barge LM, Flores E, Baum MM, VanderVelde DG, Russell MJ.

Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):4828-4833. doi: 10.1073/pnas.1812098116. Epub 2019 Feb 25.

PMID:
30804197
2.

Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.

Vincent KL, Moss JA, Marzinke MA, Hendrix CW, Anton PA, Pyles RB, Guthrie KM, Dawson L, Olive TJ, Butkyavichene I, Churchman SA, Cortez JM Jr, Fanter R, Gunawardana M, Miller CS, Yang F, Rosen RK, Vargas SE, Baum MM.

PLoS Med. 2018 Sep 28;15(9):e1002655. doi: 10.1371/journal.pmed.1002655. eCollection 2018 Sep.

3.

A Polymer-Based Extended Release System for Stable, Long-term Intracochlear Drug Delivery.

Pierstorff E, Chen S, Chaparro MP, Cortez JM Jr, Chen YJ, Ryu SY, Tsai SM, Baum MM, Yang WW, Kalinec F, Smith T, Ludwig S, Slattery WH.

Otol Neurotol. 2018 Oct;39(9):1195-1202. doi: 10.1097/MAO.0000000000001977.

PMID:
30199502
4.

Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc.

Vincent KL, Moss JA, Marzinke MA, Hendrix CW, Anton PA, Gunawardana M, Dawson LN, Olive TJ, Pyles RB, Baum MM.

PLoS One. 2018 Aug 22;13(8):e0201952. doi: 10.1371/journal.pone.0201952. eCollection 2018.

5.

User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.

Guthrie KM, Rosen RK, Vargas SE, Getz ML, Dawson L, Guillen M, Ramirez JJ, Baum MM, Vincent KL.

PLoS One. 2018 May 14;13(5):e0197269. doi: 10.1371/journal.pone.0197269. eCollection 2018.

6.

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice.

Gallay PA, Chatterji U, Kirchhoff A, Gandarilla A, Pyles RB, Baum MM, Moss JA.

Open Virol J. 2018 Feb 28;12:1-13. doi: 10.2174/1874357901812010001. eCollection 2018.

7.

Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.

Smith JM, Moss JA, Srinivasan P, Butkyavichene I, Gunawardana M, Fanter R, Miller CS, Sanchez D, Yang F, Ellis S, Zhang J, Marzinke MA, Hendrix CW, Kapoor A, Baum MM.

PLoS One. 2017 Oct 5;12(10):e0185946. doi: 10.1371/journal.pone.0185946. eCollection 2017.

8.

Dicarboxylic Acid Emissions from Aftertreatment Equipped Diesel Engines.

Bock N, Baum MM, Anderson MB, Pesta A, Northrop WF.

Environ Sci Technol. 2017 Nov 7;51(21):13036-13043. doi: 10.1021/acs.est.7b03868. Epub 2017 Oct 10.

PMID:
28952310
9.

Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice.

Gallay PA, Chatterji U, Kirchhoff A, Gandarilla A, Gunawardana M, Pyles RB, Marzinke MA, Moss JA, Baum MM.

PLoS One. 2017 Sep 7;12(9):e0184303. doi: 10.1371/journal.pone.0184303. eCollection 2017.

10.

Vaginal ecosystem modeling of growth patterns of anaerobic bacteria in microaerophilic conditions.

Medina-Colorado AA, Vincent KL, Miller AL, Maxwell CA, Dawson LN, Olive T, Kozlova EV, Baum MM, Pyles RB.

Anaerobe. 2017 Jun;45:10-18. doi: 10.1016/j.anaerobe.2017.04.014. Epub 2017 Apr 26.

11.

Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model.

Zhao C, Gunawardana M, Villinger F, Baum MM, Remedios-Chan M, Moench TR, Zeitlin L, Whaley KJ, Bohorov O, Smith TJ, Anderson DJ, Moss JA.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e02465-16. doi: 10.1128/AAC.02465-16. Print 2017 Jul.

12.

An intravaginal ring for real-time evaluation of adherence to therapy.

Moss JA, Baum MM, Easley JT, Cox DM, Smith TJ.

PLoS One. 2017 Apr 6;12(4):e0174729. doi: 10.1371/journal.pone.0174729. eCollection 2017.

13.

Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures.

Srinivasan P, Moss JA, Gunawardana M, Churchman SA, Yang F, Dinh CT, Mitchell JM, Zhang J, Fanter R, Miller CS, Butkyavichene I, McNicholl JM, Smith TJ, Baum MM, Smith JM.

PLoS One. 2016 Jun 8;11(6):e0157061. doi: 10.1371/journal.pone.0157061. eCollection 2016.

14.

Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model.

Moss JA, Butkyavichene I, Churchman SA, Gunawardana M, Fanter R, Miller CS, Yang F, Easley JT, Marzinke MA, Hendrix CW, Smith TJ, Baum MM.

Antimicrob Agents Chemother. 2016 May 23;60(6):3759-66. doi: 10.1128/AAC.00391-16. Print 2016 Jun.

15.

Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samples.

Churchman SA, Moss JA, Baum MM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 1;1017-1018:75-81. doi: 10.1016/j.jchromb.2016.02.033. Epub 2016 Mar 2.

16.

Euphorbia plant latex is inhabited by diverse microbial communities.

Gunawardana M, Hyde ER, Lahmeyer S, Dorsey BL, La Val TP, Mullen M, Yoo J, Knight R, Baum MM.

Am J Bot. 2015 Dec;102(12):1966-77. doi: 10.3732/ajb.1500223. Epub 2015 Dec 11.

17.

An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.

Baum MM, Butkyavichene I, Churchman SA, Lopez G, Miller CS, Smith TJ, Moss JA.

Int J Pharm. 2015 Nov 10;495(1):579-587. doi: 10.1016/j.ijpharm.2015.09.028. Epub 2015 Sep 16.

18.

Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxis.

Gunawardana M, Remedios-Chan M, Miller CS, Fanter R, Yang F, Marzinke MA, Hendrix CW, Beliveau M, Moss JA, Smith TJ, Baum MM.

Antimicrob Agents Chemother. 2015 Jul;59(7):3913-9. doi: 10.1128/AAC.00656-15. Epub 2015 Apr 20.

19.

Pharmacokinetics of injectable, long-acting nevirapine for HIV prophylaxis in breastfeeding infants.

Cortez JM Jr, Quintero R, Moss JA, Beliveau M, Smith TJ, Baum MM.

Antimicrob Agents Chemother. 2015 Jan;59(1):59-66. doi: 10.1128/AAC.03906-14. Epub 2014 Oct 13.

20.

An intravaginal ring for the sustained delivery of antibodies.

Gunawardana M, Baum MM, Smith TJ, Moss JA.

J Pharm Sci. 2014 Nov;103(11):3611-3620. doi: 10.1002/jps.24154. Epub 2014 Sep 17.

21.

Beta- lactam antibiotics stimulate biofilm formation in non-typeable haemophilus influenzae by up-regulating carbohydrate metabolism.

Wu S, Li X, Gunawardana M, Maguire K, Guerrero-Given D, Schaudinn C, Wang C, Baum MM, Webster P.

PLoS One. 2014 Jul 9;9(7):e99204. doi: 10.1371/journal.pone.0099204. eCollection 2014. Erratum in: PLoS One. 2014;9(12):e115784.

22.

Biofilm-specific extracellular matrix proteins of nontypeable Haemophilus influenzae.

Wu S, Baum MM, Kerwin J, Guerrero D, Webster S, Schaudinn C, VanderVelde D, Webster P.

Pathog Dis. 2014 Dec;72(3):143-60. doi: 10.1111/2049-632X.12195. Epub 2014 Jul 10.

23.

Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.

Moss JA, Srinivasan P, Smith TJ, Butkyavichene I, Lopez G, Brooks AA, Martin A, Dinh CT, Smith JM, Baum MM.

Antimicrob Agents Chemother. 2014 Sep;58(9):5125-35. doi: 10.1128/AAC.02871-14. Epub 2014 Jun 16.

24.

Isolation of PCR quality microbial community DNA from heavily contaminated environments.

Gunawardana M, Chang S, Jimenez A, Holland-Moritz D, Holland-Moritz H, La Val TP, Lund C, Mullen M, Olsen J, Sztain TA, Yoo J, Moss JA, Baum MM.

J Microbiol Methods. 2014 Jul;102:1-7. doi: 10.1016/j.mimet.2014.04.005. Epub 2014 Apr 24.

PMID:
24769406
25.

Cultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer cultures.

Pyles RB, Vincent KL, Baum MM, Elsom B, Miller AL, Maxwell C, Eaves-Pyles TD, Li G, Popov VL, Nusbaum RJ, Ferguson MR.

PLoS One. 2014 Mar 27;9(3):e93419. doi: 10.1371/journal.pone.0093419. eCollection 2014.

26.

Experimental approaches to investigating the vaginal biofilm microbiome.

Baum MM, Gunawardana M, Webster P.

Methods Mol Biol. 2014;1147:85-103. doi: 10.1007/978-1-4939-0467-9_7.

PMID:
24664828
27.

The fuel cell model of abiogenesis: a new approach to origin-of-life simulations.

Barge LM, Kee TP, Doloboff IJ, Hampton JM, Ismail M, Pourkashanian M, Zeytounian J, Baum MM, Moss JA, Lin CK, Kidd RD, Kanik I.

Astrobiology. 2014 Mar;14(3):254-70. doi: 10.1089/ast.2014.1140.

28.

Sustained delivery of commensal bacteria from pod-intravaginal rings.

Gunawardana M, Mullen M, Yoo J, Webster P, Moss JA, Baum MM.

Antimicrob Agents Chemother. 2014;58(4):2262-7. doi: 10.1128/AAC.02542-13. Epub 2014 Feb 3.

29.

Comparison of the vaginal microbial communities in women with recurrent genital HSV receiving acyclovir intravaginal rings.

Ursell LK, Gunawardana M, Chang S, Mullen M, Moss JA, Herold BC, Keller MJ, McDonald D, González A, Knight R, Baum MM.

Antiviral Res. 2014 Feb;102:87-94. doi: 10.1016/j.antiviral.2013.12.004. Epub 2013 Dec 19.

30.

Global expression of molecular transporters in the human vaginal tract: implications for HIV chemoprophylaxis.

Gunawardana M, Mullen M, Moss JA, Pyles RB, Nusbaum RJ, Patel J, Vincent KL, Wang C, Guo C, Yuan YC, Warden CD, Baum MM.

PLoS One. 2013 Oct 15;8(10):e77340. doi: 10.1371/journal.pone.0077340. eCollection 2013.

31.

Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model.

Moss JA, Malone AM, Smith TJ, Kennedy S, Nguyen C, Vincent KL, Motamedi M, Baum MM.

Antimicrob Agents Chemother. 2013 Aug;57(8):3994-7. doi: 10.1128/AAC.00547-13. Epub 2013 Jun 10.

32.

Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.

Moss JA, Malone AM, Smith TJ, Butkyavichene I, Cortez C, Gilman J, Kennedy S, Kopin E, Nguyen C, Sinha P, Hendry RM, Guenthner P, Holder A, Martin A, McNicholl J, Mitchell J, Pau CP, Srinivasan P, Smith JM, Baum MM.

Antimicrob Agents Chemother. 2012 Nov;56(11):5952-60. doi: 10.1128/AAC.01198-12. Epub 2012 Sep 10.

33.

An intravaginal ring for the simultaneous delivery of multiple drugs.

Baum MM, Butkyavichene I, Gilman J, Kennedy S, Kopin E, Malone AM, Nguyen C, Smith TJ, Friend DR, Clark MR, Moss JA.

J Pharm Sci. 2012 Aug;101(8):2833-43. doi: 10.1002/jps.23208. Epub 2012 May 22.

34.

Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ring.

Keller MJ, Malone AM, Carpenter CA, Lo Y, Huang M, Corey L, Willis R, Nguyen C, Kennedy S, Gunawardana M, Guerrero D, Moss JA, Baum MM, Smith TJ, Herold BC.

J Antimicrob Chemother. 2012 Aug;67(8):2005-12. doi: 10.1093/jac/dks151. Epub 2012 May 3.

35.

Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings.

Moss JA, Baum MM, Malone AM, Kennedy S, Kopin E, Nguyen C, Gilman J, Butkyavichene I, Willis RA, Vincent KL, Motamedi M, Smith TJ.

AIDS. 2012 Mar 27;26(6):707-10. doi: 10.1097/QAD.0b013e3283509abb.

36.

Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.

Moss JA, Malone AM, Smith TJ, Kennedy S, Kopin E, Nguyen C, Gilman J, Butkyavichene I, Vincent KL, Motamedi M, Friend DR, Clark MR, Baum MM.

Antimicrob Agents Chemother. 2012 Feb;56(2):875-82. doi: 10.1128/AAC.05662-11. Epub 2011 Nov 28.

37.

Microbial biofilms on the surface of intravaginal rings worn in non-human primates.

Gunawardana M, Moss JA, Smith TJ, Kennedy S, Kopin E, Nguyen C, Malone AM, Rabe L, Schaudinn C, Webster P, Srinivasan P, Sweeney ED, Smith JM, Baum MM.

J Med Microbiol. 2011 Jun;60(Pt 6):828-37. doi: 10.1099/jmm.0.028225-0. Epub 2011 Mar 10.

38.

Artificial photosynthesis: semiconductor photocatalytic fixation of CO2 to afford higher organic compounds.

Hoffmann MR, Moss JA, Baum MM.

Dalton Trans. 2011 May 21;40(19):5151-8. doi: 10.1039/c0dt01777a. Epub 2011 Mar 3.

PMID:
21373667
39.

Characterization of structures in biofilms formed by a Pseudomonas fluorescens isolated from soil.

Baum MM, Kainović A, O'Keeffe T, Pandita R, McDonald K, Wu S, Webster P.

BMC Microbiol. 2009 May 21;9:103. doi: 10.1186/1471-2180-9-103.

40.

Determination of phosphate/arsenate by a modified molybdenum blue method and reduction of arsenate by S(2)O(4)(2-).

Tsang S, Phu F, Baum MM, Poskrebyshev GA.

Talanta. 2007 Mar 15;71(4):1560-8. doi: 10.1016/j.talanta.2006.07.043. Epub 2006 Aug 28.

PMID:
19071492
41.

Hydrogen cyanide exhaust emissions from in-use motor vehicles.

Baum MM, Moss JA, Pastel SH, Poskrebyshev GA.

Environ Sci Technol. 2007 Feb 1;41(3):857-62.

PMID:
17328194
42.

Non-invasive measurement of cardiac output: evaluation of new infrared absorption spectrometer.

Baum MM, Moss JA, Kumar S, Wagner PD.

Respir Physiol Neurobiol. 2006 Sep 28;153(2):191-201. Epub 2005 Dec 2.

PMID:
16326150
43.

Multicomponent remote sensing of vehicle exhaust by dispersive absorption spectroscopy. 2. Direct on-road ammonia measurements.

Baum MM, Kiyomiya ES, Kumar S, Lappas AM, Kapinus VA, Lord HC 3rd.

Environ Sci Technol. 2001 Sep 15;35(18):3735-41. Erratum in: Environ Sci Technol. 2002 Nov 1;36(21):4705..

PMID:
11783653

Supplemental Content

Support Center